Showing results (101-110 of 1,846) with videos related to
Sort By:
Pageof 185
Journal of Child and Adolescent Psychopharmacology|June 14, 2006
Long-term use of risperidone in children with disruptive behavior disorders and subaverage intelligence: efficacy, safety, and tolerabilityMagali Reyes, Jan Croonenberghs, Ilse Augustyns, et al.Journal of Child and Adolescent Psychopharmacology|June 14, 2006
The effect of long-term antipsychotic treatment on prolactinJud StallerJournal of Child and Adolescent Psychopharmacology|June 14, 2006
A one-year open-label trial of risperidone augmentation in lithium nonresponder youth with preschool-onset bipolar disorderMani N Pavuluri, David B Henry, Julie A Carbray, et al.Journal of Child and Adolescent Psychopharmacology|June 14, 2006
Once-daily OROS methylphenidate is safe and well tolerated in adolescents with attention-deficit/hyperactivity disorderJames J McGough, Keith McBurnett, Oscar Bukstein, et al.Journal of Child and Adolescent Psychopharmacology|June 14, 2006
Concomitant use of atomoxetine and OROS-methylphenidate in a 10-year-old child suffering from attention-deficit/hyperactivity disorder with comorbid bipolar disorder and Tourette syndromeSol Jaworowski, Fortu Benarroch, Varda Gross-TsurJournal of Child and Adolescent Psychopharmacology|June 24, 2021
Lack of Associations Between C-Reactive Protein and Mood and Anxiety Symptoms in AdolescentsQi Liu, Benjamin A Ely, Sherry Simkovic, et al.Journal of Child and Adolescent Psychopharmacology|May 25, 2022
Efficacy, Tolerability, and Acceptance of Long-Lasting Antipsychotics in Children and Adolescents: A Systematic ReviewXavier Benarous, Guillaume Cottin, Hélène Lahaye, et al.Journal of Child and Adolescent Psychopharmacology|July 20, 2021
Irritability Is Associated with Illness Severity and Anhedonia Is Associated with Functional Impairment Among Depressed Children and AdolescentsSamantha N Sherwood, Jennifer K Youngstrom, Robert L Findling, et al.Journal of Child and Adolescent Psychopharmacology|May 19, 2022
The Impact of Pharmacotherapy of Childhood-Onset Psychiatric Disorders on the Development of Substance Use DisordersTimothy E Wilens, Diana W Woodward, Je Deuk Ko, et al.Journal of Child and Adolescent Psychopharmacology|May 9, 2022
Executive Functioning in Pediatric Anxiety and Its Relationship to Selective Serotonin Reuptake Inhibitor Treatment Response: A Double-Blind, Placebo-Controlled TrialW Thomas Baumel, Jeffrey A Mills, Heidi K Schroeder, et al.Pageof 185